About
New England Biolabs (NEB) is a privately held biotechnology company headquartered in Ipswich, Massachusetts, that leads the discovery and manufacture of recombinant and native enzymes for molecular biology. The company offers the most extensive portfolio of enzymes for genomic research, covering PCR, gene expression, next‑generation sequencing sample preparation, synthetic biology, glycobiology, epigenetics, and RNA analysis. NEB differentiates itself through strategic partnerships that accelerate the deployment of emerging technologies into molecular diagnostics and nucleic‑acid vaccine markets. With a worldwide distribution network spanning 12 countries, NEB delivers its products through exclusive distributors, agents, and subsidiaries, ensuring rapid access to researchers and developers worldwide.
